# FDA 483 - Daniel Fred Goodman, M.D. - November 25, 2024

Source: https://www.keypedia.com/records/483/daniel-fred-goodman-md/1ba20ce0-0f7f-4212-a7e0-54ef4c603d0d

> FDA 483 for Daniel Fred Goodman, M.D. on November 25, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Daniel Fred Goodman, M.D.
- Inspection Date: 2024-11-25
- Product Type: other
- Office Name: San Francisco District Office
- Summary: The FDA inspected Daniel Fred Goodman, M.D., a clinical investigator in San Francisco, CA, from November 20-25, 2024. The inspection revealed that the clinical investigator failed to properly investigate and document protocol deviations, specifically neglecting to assess their impact on subject safety and data integrity. This indicates a serious lapse in adherence to investigational plans and regulatory requirements.

## Related Documents

- [483 - 2021-12-13](https://www.keypedia.com/records/483/daniel-fred-goodman-md/317bef58-c03c-4dc7-b1c4-831ec0289166)

## Related Officers

- [Scott N. Lim](https://www.keypedia.com/people/scott-n-lim/d5e7745a-d804-48d1-8f3b-a94a8d4aed8a)

Company: https://www.keypedia.com/companies/daniel-fred-goodman-md/75721ae4-0e50-488f-bbb5-22b050bc0249

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df